Iambic Therapeutics Insider Bought Shares Worth $11,500,000, According to a Recent SEC Filing

MT newswire2026/10/20 08:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:05 AM EDT, 10/20/2026 (MT Newswires) -- Evan Lockwood Rachlin, Director, on October 16, 2026, executed a purchase for 718,750 shares in Iambic Therapeutics (IAM) for $11,500,000. Following the Form 4 filing with the SEC, Rachlin has control over a total of 2,646,002 common shares of the company, with 2,646,002 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1997038/000215167826000007/xslF345X05/form4-10192026_111032.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Iambic Therapeutics Insider Bought Shares Worth $11,500,000, According to a Recent SEC Filing

You may also like

Crypto prices